Heterogeneity of Residual Disease After Neoadjuvant Systemic Therapy in Breast Cancer

85

Heterogeneity of Residual Disease After Neoadjuvant Systemic Therapy in Breast Cancer

Tags:

Previous Article

Defining microglial-synapse interactions

Clinical sequelae of gut microbiome development and disruption in hospitalized p...

Related Posts

IL-1β+ macrophages and the control of pathogenic inflammation in cancer

IL-1β+ macrophages and the control of pathogenic inflam...

95

Epigenetic regulation of hematopoietic stem cell fate

Epigenetic regulation of hematopoietic stem cell fate

95

Analog of prolactin-releasing peptide reduces body weight primarily through sustained fatty acid oxidation rather than hypophagia

Analog of prolactin-releasing peptide reduces body weig...

41